There are 203 resources available
95O - Atezolizumab plus ipatasertib shows promise in extending survival for patients with PI3K/AKT/PTEN-altered advanced solid tumors: An exploratory analysis of the ROME trial
Presenter: Andrea Botticelli
Session: Oral abstract session 1
Resources:
Abstract
Slides
Webcast
28O - TalaCom: Phase Ib investigator-initiated trial combining talazoparib and axitinib in patients with DNA damage response mutated cancers or BRCA1/2 wildtype ovarian cancer incorporating prospective intrapatient dose titration
Presenter: Natalie Ngoi
Session: Oral abstract session 1
Resources:
Abstract
Invited Discussant 95O and 28O
Presenter: Christophe Le Tourneau
Session: Oral abstract session 1
Resources:
Slides
Webcast
Q&A and discussion
Session: Oral abstract session 1
Resources:
Webcast
1P - Multimodal integration of radiology, pathology and transcriptomics for prediction of response to neoadjuvant therapy in patients with retroperitoneal liposarcoma
Presenter: Lijie Ma
Session: Poster Display & Cocktail
Resources:
Abstract
2P - Using machine learning (ML) and explainable artificial intelligence (AI) to accurately predict immune-checkpoint inhibitor (ICI) response in small cell (SCLC) and non-small cell (NSCLC) lung cancer patients
Presenter: Lakshya Sharma
Session: Poster Display & Cocktail
Resources:
Abstract
3P - Predicting immunotherapy-related adverse events in melanoma patients using machine learning algorithms and explainable artificial intelligence
Presenter: Lakshya Sharma
Session: Poster Display & Cocktail
Resources:
Abstract
4P - Machine learning-based prediction of survival in patients with metastatic renal cell carcinoma receiving first-line immunotherapy
Presenter: Ahmed Elgebaly
Session: Poster Display & Cocktail
Resources:
Abstract
5P - Radiomic prediction of prognostic outcomes and immune profile in breast cancer: Focus on STAT3 expression
Presenter: dong pan
Session: Poster Display & Cocktail
Resources:
Abstract
6P - vAO - Variant Annotator for OncoKB: A simplified interface to identify targeted therapies for somatic tumors
Presenter: Vigneshwaran Gurunadan
Session: Poster Display & Cocktail
Resources:
Abstract